Your browser doesn't support javascript.
loading
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012-2013 to 2018-2019 Seasons, Quebec, Canada.
Carazo, Sara; Guay, Charles-Antoine; Skowronski, Danuta M; Amini, Rachid; Charest, Hugues; De Serres, Gaston; Gilca, Rodica.
Afiliação
  • Carazo S; Biological Risks Unit, Institut National de Santé Publique du Québec, Quebec City, Quebec, Canada.
  • Guay CA; Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.
  • Skowronski DM; Biological Risks Unit, Institut National de Santé Publique du Québec, Quebec City, Quebec, Canada.
  • Amini R; Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.
  • Charest H; Pulmonary Hypertension Research Group, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, Quebec, Canada.
  • De Serres G; Département des Sciences de la Santé Communautaire, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Gilca R; Communicable Diseases and Immunization Services, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Clin Infect Dis ; 78(3): 765-774, 2024 03 20.
Article em En | MEDLINE | ID: mdl-37819010
ABSTRACT

BACKGROUND:

Influenza immunization programs aim to reduce the risk and burden of severe outcomes. To inform optimal program strategies, we monitored influenza hospitalizations over 7 seasons, stratified by age, comorbidity, and vaccination status.

METHODS:

We assembled data from 4 hospitals involved in an active surveillance network with systematic collection of nasal samples and polymerase chain reaction testing for influenza virus in all patients admitted through the emergency department with acute respiratory infection during the 2012-2013 to 2018-2019 influenza seasons in Quebec, Canada. We estimated seasonal, population-based incidence of influenza-associated hospitalizations by subtype predominance, age, comorbidity, and vaccine status, and derived the number needed to vaccinate to prevent 1 hospitalization per stratum.

RESULTS:

The average seasonal incidence of influenza-associated hospitalization was 89/100 000 (95% confidence interval, 86-93), lower during A(H1N1) (49-82/100 000) than A(H3N2) seasons (73-143/100 000). Overall risk followed a J-shaped age pattern, highest among infants 0-5 months and adults ≥75 years old. Hospitalization risks were highest for children <5 years old during A(H1N1) but for highest adults aged ≥75 years during A(H3N2) seasons. Age-adjusted hospitalization risks were 7-fold higher among individuals with versus without comorbid conditions (214 vs 30/100 000, respectively). The number needed to vaccinate to prevent hospitalization was 82-fold lower for ≥75-years-olds with comorbid conditions (n = 1995), who comprised 39% of all hospitalizations, than for healthy 18-64-year-olds (n = 163 488), who comprised just 6% of all hospitalizations.

CONCLUSIONS:

In the context of broad-based influenza immunization programs (targeted or universal), severe outcome risks should be simultaneously examined by subtype, age, comorbidity, and vaccine status. Policymakers require such detail to prioritize promotional efforts and expenditures toward the greatest and most efficient program impact.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H1N1 Limite: Adult / Child / Child, preschool / Humans / Infant País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H1N1 Limite: Adult / Child / Child, preschool / Humans / Infant País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article